OncoVista Innovative Therapies, Inc. (OVIT)

OVIT Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010
Period Ending	Sep 30, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Selling, General & Admin	2.65	1.88	0.62	0.88	1.04	1.95
Research & Development	0.75	0.67	0.9	1.1	1.16	0.45
Operating Expenses	3.4	2.55	1.52	1.98	2.2	2.4
Operating Income	-3.4	-2.55	-1.52	-1.98	-2.2	-2.4
Interest Expense	-0.03	-0.01	-	-0.01	-0.02	-0.15
Interest & Investment Income	-	-	0	0	0.01	-
Other Non Operating Income (Expenses)	0.16	0.01	0.07	0.24	-0.01	-0.26
EBT Excluding Unusual Items	-3.27	-2.54	-1.45	-1.74	-2.23	-2.81
Other Unusual Items	-	-	-	0.11	-	0.52
Pretax Income	-3.27	-2.54	-1.45	-1.63	-2.23	-2.29
Earnings From Continuing Operations	-3.27	-2.54	-1.45	-1.63	-2.23	-2.29
Earnings From Discontinued Operations	-	-	-	-	0.2	12.39
Net Income	-3.27	-2.54	-1.45	-1.63	-2.03	10.1
Net Income to Common	-3.27	-2.54	-1.45	-1.63	-2.03	10.1
Shares Outstanding (Basic)	22	22	22	22	21	20
Shares Outstanding (Diluted)	22	22	22	22	21	20
Shares Change (YoY)	2.66%	0.11%	0.54%	0.95%	4.04%	11.17%
EPS (Basic)	-0.15	-0.12	-0.07	-0.08	-0.10	0.49
EPS (Diluted)	-0.15	-0.12	-0.07	-0.08	-0.10	0.49
Free Cash Flow	-0.26	-0.23	-0.47	-1.55	-1.61	-0.55
Free Cash Flow Per Share	-0.01	-0.01	-0.02	-0.07	-0.08	-0.03
EBITDA	-3.4	-2.55	-1.52	-1.97	-2.19	-2.39
D&A For EBITDA	0	0	0	0.01	0.01	0.01
EBIT	-3.4	-2.55	-1.52	-1.98	-2.2	-2.4

Source: S&P Global Market Intelligence. Standard template. Financial Sources.